IndicaonsforUse:REVOLVE
TM
Systemisusedforaspiraon,harvesng,ltering,andtransferringofautologousadipose
ssueforaesthecbodycontouring.Thesystemshouldbeusedwithalegallymarketedvacuumoraspiratorapparatus
asasourceofsucon.Ifharvestedfatistobere-implanted,theharvestedfatisonlytobeusedwithoutanyaddional
manipulaon.
REVOLVE
TM
Systemisintendedforuseinthefollowingsurgicalspecialeswhentheaspiraonofsossueisdesired:plasc
andreconstrucvesurgery,gastrointesnalandaliatedorgansurgery,urologicalsurgery,generalsurgery,orthopedicsurgery,
gynecologicalsurgery,thoracicsurgery,andlaparoscopicsurgery.
Contraindicaons:Contraindicaonstoautologousfattransferincludethepresenceofanydiseaseprocessesthatadversely
aectwoundhealing,andpooroverallhealthstatusoftheindividual.
Warnings:
1. REVOLVE™Systemmustbeusedwithinthesamesurgicalprocedure.ReuseofREVOLVE™Systeminthesamepaentin
asubsequentsurgicalprocedure,orformorethanonepaent,mayresultininfeconand/ortransmissionof
communicablediseases.
2. Donotusetheproductifsterilepackagingisdamaged.
3. Thisdevicewillnot,inandofitself,producesignicantweightreducon.
4. Thisdeviceshouldbeusedwithextremecauoninpaentswithchronicmedicalcondionssuchasdiabetes,heart,lung,
orcirculatorysystemdiseaseorobesity.
5. Thevolumeofbloodlossandendogenousbodyuidlossmayadverselyaectintraand/orpostoperavehemodynamic
stabilityandpaentsafety.Thecapabilityofprovidingadequate,melyreplacementisessenalforpaentsafety.
Precauons:
1. Thisdeviceisdesignedtoremovelocalizeddepositsofexcessfatthroughsmallincisionandsubsequentlytransferthe
ssuebacktothepaent.
2. Useofthisdeviceislimitedtothosephysicianswho,bymeansofformalprofessionaltrainingorsanconed
connuingmedicaleducaon(includingsupervisedoperaveexperience),haveaainedprociencyinsucon
lipoplastyandssuetransfer.
3. Resultsofthisprocedurewillvarydependinguponpaentage,surgicalsite,andexperienceofthephysician.
4. Resultsofthisproceduremayormaynotbepermanent.
5. Theamountoffatremovedshouldbelimitedtothatnecessarytoachieveadesiredcosmeceect.
6. Fillingthedevicewithadiposessueoverthemaximumllvolumelinecanleadtoocclusionofthemeshresulngin
meshtear.
AdverseEects:
1. Somecommonadverseeectsassociatedwithautologousfattransferareasymmetry,over-and/orunder-correconofthe
treatmentsite,ssuelumps,bleeding,andscarring.
2. PotenaladverseeectsassociatedwithREVOLVE™Systemincludefatnecrosis,cystformaon,infecon,chronicforeign
bodyresponse,allergicreaconandinammaon.
Theexpiraondateprovidedonproductlabelsareinthefollowingformat:4digityear,2digitmonth,and2digitday
(YYYY-MM-DD).
Thisproduct,includingitspackagingandcomponents,isnotmadewithnaturalrubberlatex.
LifeCellCorporaon
OneMillenniumWay
Branchburg,NJ08876
1-800-433-8871
PatentedintheUS.Pleaseseewww.allergan.com/patents.AddionalpatentsmaybependingorissuedintheUSand
elsewhere.Allergan®anditsdesignaretrademarksofAllergan,Inc.REVOLVE™isatrademarkofLifeCellCorporaon,an
Allerganaliate.©2017Allergan.Allrightsreserved.
L00-7006RevG